Multiple GPRC5D Agents For Myeloma Raise Questions On Positioning

Bispecifics Could Be Better For More Vulnerable Patients

 
• By Alaric DeArment
  
Data for multiple GPRC5D programs were presented at ASH 2022 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D